Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel
· Delayed Price · Currency is ILS · Price in ILA 33.50
+1.00 (3.08%)
Apr 29, 2026, 5:24 PM IDT
TLV:CBI Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1.69 | 3.95 | 5.73 | 7.44 | 53.05 | Upgrade
|
| Trading Asset Securities | - | 1.06 | 7.63 | 5.44 | - | Upgrade
|
| Cash & Short-Term Investments | 1.69 | 5.01 | 13.36 | 12.89 | 53.05 | Upgrade
|
| Cash Growth | -66.29% | -62.48% | 3.65% | -75.71% | -71.56% | Upgrade
|
| Accounts Receivable | - | - | - | - | 5.53 | Upgrade
|
| Other Receivables | - | - | 0.02 | 0.65 | 1.9 | Upgrade
|
| Receivables | - | - | 0.02 | 0.65 | 7.44 | Upgrade
|
| Inventory | - | - | - | - | 3.73 | Upgrade
|
| Prepaid Expenses | 0.18 | 0.28 | 0.82 | 2.59 | 2.68 | Upgrade
|
| Other Current Assets | 0.58 | 0.51 | 0.49 | 0.52 | 10.71 | Upgrade
|
| Total Current Assets | 2.46 | 5.8 | 14.69 | 16.64 | 77.61 | Upgrade
|
| Property, Plant & Equipment | 1.35 | 1.53 | 4.73 | 5.09 | 18.06 | Upgrade
|
| Long-Term Investments | 37.84 | 60.14 | 138.22 | 155.69 | 127.83 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 215.78 | Upgrade
|
| Other Long-Term Assets | 0.19 | 0.22 | 0.75 | 5.28 | 5.63 | Upgrade
|
| Total Assets | 41.83 | 67.69 | 158.39 | 182.69 | 444.92 | Upgrade
|
| Accounts Payable | - | - | - | - | 14.6 | Upgrade
|
| Accrued Expenses | 0.78 | 0.58 | 1.16 | 1.01 | 8.29 | Upgrade
|
| Current Portion of Long-Term Debt | 16.19 | 19.17 | 4.97 | - | 6.24 | Upgrade
|
| Current Portion of Leases | 0.17 | 0.15 | 0.47 | 1.85 | 2.43 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 2.37 | Upgrade
|
| Other Current Liabilities | 0.42 | 0.1 | 0.07 | 0.05 | 1.72 | Upgrade
|
| Total Current Liabilities | 17.56 | 20 | 6.66 | 2.91 | 35.65 | Upgrade
|
| Long-Term Debt | - | - | 25.97 | 27.39 | 35.86 | Upgrade
|
| Long-Term Leases | 1.4 | 1.53 | 4.35 | 7.49 | 9.25 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 24.52 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 1.26 | Upgrade
|
| Total Liabilities | 18.95 | 21.52 | 36.98 | 37.79 | 106.55 | Upgrade
|
| Common Stock | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | Upgrade
|
| Additional Paid-In Capital | 1,311 | 1,297 | 1,296 | 1,296 | 1,295 | Upgrade
|
| Retained Earnings | -1,408 | -1,394 | -1,332 | -1,301 | -1,239 | Upgrade
|
| Treasury Stock | -10 | -10 | -10 | -10 | -10 | Upgrade
|
| Comprehensive Income & Other | 125.02 | 142.64 | 143.76 | 139.37 | 125.29 | Upgrade
|
| Total Common Equity | 20.2 | 36.63 | 99.36 | 126.03 | 172.59 | Upgrade
|
| Minority Interest | 2.68 | 9.53 | 22.05 | 18.87 | 165.78 | Upgrade
|
| Shareholders' Equity | 22.88 | 46.17 | 121.41 | 144.9 | 338.37 | Upgrade
|
| Total Liabilities & Equity | 41.83 | 67.69 | 158.39 | 182.69 | 444.92 | Upgrade
|
| Total Debt | 17.76 | 20.84 | 35.76 | 36.73 | 53.78 | Upgrade
|
| Net Cash (Debt) | -16.07 | -15.83 | -22.4 | -23.85 | -0.73 | Upgrade
|
| Net Cash Per Share | -0.10 | -0.10 | -0.14 | -0.15 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 156.85 | 156.85 | 156.85 | 156.85 | 156.85 | Upgrade
|
| Total Common Shares Outstanding | 156.85 | 156.85 | 156.85 | 156.85 | 156.85 | Upgrade
|
| Working Capital | -15.1 | -14.2 | 8.03 | 13.73 | 41.96 | Upgrade
|
| Book Value Per Share | 0.13 | 0.23 | 0.63 | 0.80 | 1.10 | Upgrade
|
| Tangible Book Value | 20.2 | 36.63 | 99.36 | 126.03 | -43.19 | Upgrade
|
| Tangible Book Value Per Share | 0.13 | 0.23 | 0.63 | 0.80 | -0.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.